Back

Is GRACE 2.0 a better predictor of post-MI mortality than GRACE in patients with known diabetes compared to those without?

26 April 2024 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: How should we assess cardiovascular risk? Scores, prediction algorithms and analysis methods Clinical Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Biji Soman

James Paget University Hospital, Great Yarmouth (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Heterogeneous associations of traditional atherosclerotic risk factors and long-term complications in different arterial territories: the EPIC Norfolk prospective population cohort
Ms M. van den Bogaart (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Optimization and validation of high, intermediate and low risk cut-off points in risk functions for primary cardiovascular prevention. The ORESTES project.
Ms N. Herrera Marin (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Real-world evaluation of performance and practical utility of multi-biomarker risk report for cardiovascular and other chronic diseases
Doctor S. Kerminen (Helsinki, FI)
Abstract Slides
Presentation thumbnail
Improved sex-specific cardiovascular disease risk prediction using machine learning and explainable artificial intelligence
Ms V. De Martin T (Trondheim, NO)
Abstract Slides
Presentation thumbnail
Intima-media thickness measured at the common carotid artery, carotid bifurcation, and internal carotid artery in cardiovascular risk assessment
Doctor L. Seekircher (Innsbruck, AT)
Abstract Slides

Access the full session

Session thumbnail
How should we assess cardiovascular risk? Scores, prediction algorithms and analysis methods

The Event

Event poster

ESC Preventive Cardiology 2024

26 April 2024 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources